Technology
Live Price
Offline$5.25
-11.64% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cellebrite DI Ltd. (CLBTW) is a Technology stock with a market cap of $1.06B. The stock last traded around $5.25. Baseline metrics include revenue growth of +18.6%, EPS growth of +123.7%, a dividend yield of 0.0%. What stands out right now is revenue +18.6%, EPS +123.7%, free cash flow +28.1% with operating margin 14.0% and ROIC 10.0%. Valuation already assumes a fairly strong business story at P/E 46.1 and price/sales 7.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CLBTW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CLBTW
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CLBTW Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CLBTW and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$246.2M
-9.0% YoY
FY Net Income
$71.4M
-40.9% YoY
Free Cash Flow
$27.9M
+143.1% YoY
Revenue Growth
+18.6%
EPS Growth
+123.7%
Gross Margin
84.2%
Net Margin
16.5%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 476M | 401M | 325M | 271M | 246M |
| Gross Profit | 401M | 339M | 272M | 220M | 204M |
| Operating Income | 66M | 57M | 33M | 1M | 14M |
| EBITDA | 78M | 68M | -65M | 130M | 89M |
| Net Income | 78M | -283M | -81M | 121M | 71M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 124M | 192M | 190M | 88M | 146M |
| Total Assets | 939M | 691M | 533M | 403M | 340M |
| Total Liabilities | 455M | 355M | 499M | 329M | 413M |
| Shareholder Equity | 484M | 336M | 34M | 74M | -73M |
| Total Debt | 23M | 11M | 14M | 15M | 0 |
| Net Debt | -102M | -181M | -175M | -72M | -146M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
36M
+75.2% YoY
Capital Expenditures
8M
+10.7% YoY
Free Cash Flow
28M
+143.1% YoY
Key ratios
Gross Margin
84.2%
Operating Margin
14.0%
Net Margin
16.5%
ROE
18.4%
Debt / Equity
0.05x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.